LTF and Recurrent upper respiratory tract infections: Hanstock et al. (90) observed that patients affected by upper respiratory tract infection had a significantly lower concentration of tear lysozyme and/or lactoferrin compared to healthy volunteers, suggesting that lysozyme and lactoferrin may serve as clinically relevant biomarkers for mucosal immune competence.